Related Experiment Video
Updated: Mar 14, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Multidimensional mechanisms of quercetin in diabetic kidney disease
Zhaoyuan Gong1, Qianzi Che1, Chuxuan Wang2
1Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing, China.
Abstract:
Quercetin is a flavonoid compound that has demonstrated substantial potential in the treatment of diabetic kidney disease (DKD). However, there is still a lack of systematic research on the exact mechanism of action of quercetin. This review discusses the druggability, molecular targets, and signaling pathways of quercetin in DKD treatment. We retrieved the latest research on the pharmacological effects and mechanisms related to quercetin from PubMed and Scopus as of June 2025 (2012-2025). Evidence suggests that quercetin has the potential to eliminate senescent cells in DKD. Network pharmacology was used to predict the targets and pathways of quercetin in targeting cellular senescence to treat DKD. Using on existing research, it was further confirmed that quercetin can effectively act on hub target and pathway. The mechanism of quercetin therapy in DKD was summarized from three dimensions: inflammation, oxidative stress, and cell death. This review highlights the potential of quercetin for treating DKD by providing a biological basis for its mechanism of action and its use as a senolytic drug for this disease.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Action of Diuretics
Heart Failure Drugs: Diuretics

